Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Perspective Therapeutics (CATX) Equity Ratio (2016 - 2026)

Perspective Therapeutics' Equity Ratio history spans 16 years, with the latest figure at 0.85 for Q1 2026.

  • On a quarterly basis, Equity Ratio fell 2.13% to 0.85 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.85, a 2.13% decrease, with the full-year FY2025 number at 0.78, down 9.0% from a year prior.
  • Equity Ratio hit 0.85 in Q1 2026 for Perspective Therapeutics, up from 0.78 in the prior quarter.
  • Over the last five years, Equity Ratio for CATX hit a ceiling of 0.96 in Q1 2022 and a floor of 0.77 in Q4 2023.
  • Historically, Equity Ratio has averaged 0.87 across 5 years, with a median of 0.86 in 2025.
  • Biggest five-year swings in Equity Ratio: fell 18.35% in 2023 and later grew 10.96% in 2024.
  • Tracing CATX's Equity Ratio over 5 years: stood at 0.94 in 2022, then decreased by 18.35% to 0.77 in 2023, then increased by 10.96% to 0.85 in 2024, then decreased by 9.0% to 0.78 in 2025, then increased by 9.07% to 0.85 in 2026.
  • Business Quant data shows Equity Ratio for CATX at 0.85 in Q1 2026, 0.78 in Q4 2025, and 0.82 in Q3 2025.